Syvolap, V.V. and Vizir-Tronova, O.V. 2017. Influence of additional risk factors on the antihypertensive efficacy of eprosartan and telmisartan in patients with essential hypertension. Pathologia. 3 (Dec. 2017). DOI:https://doi.org/10.14739/2310-1237.2017.3.118311.